Organon & Co.
USD13.55
+0.05 (+0.37%)
CEO
Joseph T. Morrissey Jr.
IPO Date
2021-05-14
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
US
Open
$13.51
Prev. Close
$13.50
Day Low
$13.49
Day High
$13.55
52W Low
$5.69
52W High
$13.55
Market Cap
$3.56B
Volume
1.07M
| 4.4 |
| 31 Dec 2023 | FY | 59.8% | 16.3% | -1461.4% | 8.5% | -127.59 | 1.54 | 3.6 |
| 31 Dec 2022 | FY | 62.8% | 14.9% | -102.8% | 8.4% | -10.22 | 1.56 | 7.7 |
| 31 Dec 2021 | FY | 62.2% | 21.4% | -89.6% | 12.6% | -6.21 | 1.45 | 5.7 |
| 31 Dec 2020 | FY | 67.6% | 33.1% | 39.4% | 21.4% | 0.01 | 1.33 | 3.9 |
| 31 Dec 2019 | FY | 70.8% | 41.4% | 45.7% | 30.5% | 0.03 | 2.95 | 2.6 |
| 31 Dec 2018 | FY | 52.0% | 22.0% | 33.9% | 20.5% | 0.02 | 2.40 | 3.9 |
| 31 Dec 2017 | FY | 56.3% | 17.2% | 0.0% | 0.0% | 0.00 | 0.00 | 4.7 |
| -2.3 |
| 30 Sept 2025 | Q3 | 53.5% | 10.0% | 17.7% | 1.2% | 9.74 | 1.75 | 4.3 |
| 30 Jun 2025 | Q2 | 54.8% | 9.1% | 19.8% | 1.1% | 12.14 | 1.65 | 4.3 |
| 31 Mar 2025 | Q1 | 55.6% | 5.8% | 16.1% | 0.7% | 16.52 | 1.67 | 11.0 |
| 31 Dec 2024 | Q4 | 56.3% | 6.8% | 23.1% | 0.8% | 19.14 | 1.60 | 8.8 |
| 30 Sept 2024 | Q3 | 58.3% | 22.7% | 72.8% | 2.8% | 17.75 | 1.70 | 3.4 |
| 30 Jun 2024 | Q2 | 58.4% | 12.1% | 135.4% | 1.6% | 60.11 | 1.64 | 6.7 |
| 31 Mar 2024 | Q1 | 59.0% | 12.4% | 418.8% | 1.7% | 181.54 | 1.65 | 5.9 |
| 31 Dec 2023 | Q4 | 57.3% | 34.2% | -780.0% | 4.5% | -127.59 | 1.54 | 1.7 |